Uehara Kyokun, Matsuda Hitoshi, Inoue Yosuke, Omura Atsushi, Seike Yoshimasa, Sasaki Hiroaki, Kobayashi Junjiro
Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan.
Ann Vasc Dis. 2017 Sep 25;10(3):211-6. doi: 10.3400/avd.oa.17-00013.
: Although endovascular repair for abdominal aortic aneurysm has been found to be beneficial in very elderly patients, some patients have contraindications to this procedure. For nonagenarians, the results of open repair remain unclear. The purpose of this study was to compare the outcomes of open vs. endovascular repair for abdominal aortic aneurysm in nonagenarian patients. : Fourteen patients undergoing open surgical repair and 24 undergoing endovascular repair for abdominal aortic aneurysm were evaluated. There was no significant difference in early mortality between the open and endovascular groups (0% vs. 4.1%, p=0.16). The open repair group required much longer hospital stays (26.4 vs. 10.6 days, respectively, p=0.003). Finally, 12 patients (86%) undergoing open repair vs. 21 (88%) undergoing endovascular repair returned home (p=0.49). During a mean follow-up period of 23.4±23.5 months, cumulative estimated 1- and 3-year survival rates were 90.0% and 48.0%, respectively in the open repair group and 90.6% and 54.9%, respectively in the endovascular repair group (p=0.51). : Although endovascular repair for abdominal aortic aneurysm was superior in terms of recovery, the results of conventional open repair were acceptable even in nonagenarian patients. Open repair remains an alternative for patients with contraindications to endovascular repair.
尽管已发现腹主动脉瘤的血管内修复术对高龄患者有益,但一些患者对此手术存在禁忌证。对于九旬老人,开放修复术的效果仍不明确。本研究的目的是比较九旬老人腹主动脉瘤开放修复术与血管内修复术的疗效。对14例行腹主动脉瘤开放手术修复的患者和24例行血管内修复的患者进行了评估。开放组和血管内组的早期死亡率无显著差异(0%对4.1%,p = 0.16)。开放修复组的住院时间要长得多(分别为26.4天和10.6天,p = 0.003)。最后,12例(86%)接受开放修复的患者与21例(88%)接受血管内修复的患者回家(p = 0.49)。在平均23.4±23.5个月的随访期内,开放修复组的累计1年和3年生存率分别为90.0%和48.0%,血管内修复组分别为90.6%和54.9%(p = 0.51)。尽管腹主动脉瘤的血管内修复术在恢复方面更具优势,但即使在九旬老人中,传统开放修复术的效果也是可以接受的。对于有血管内修复禁忌证的患者,开放修复术仍是一种选择。